Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Chemistry, Properties, and Uses of Commercial Fluorinated Surfactants Read chapter Read first chapter

2012 | OriginalPaper | Chapter

Human Biomonitoring of Perfluorinated Compounds

Authors : Michael Wilhelm, Jürgen Hölzer

Published in: Polyfluorinated Chemicals and Transformation Products

Publisher: Springer Berlin Heidelberg

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Human biomonitoring (HBM) is a scientific technique for assessing human exposures to natural and synthetic compounds in the environment. It is based on analysis of human tissues and fluids. It provides the only direct method of determining if people have been exposed to particular substances, what the magnitudes of their exposures are, and how these may be changing over time. In HBM, the most commonly studied perfluorinated compounds are the perfluorinated sulfonates and the perfluorinated carboxylates. Among these perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) are of greatest concern. Our first biomonitoring study from autumn 2006 evidenced that plasma PFOA concentrations of residents from Arnsberg were 4.5–8.3 times higher than those in reference groups. A 10–20% reduction of PFOA plasma levels in residents from Arnsberg, Sauerland, Germany, was observed in our 1-year follow-up study. A further but still slow decline of the PFOA load was confirmed in the 2-year follow-up study. Detailed monitoring of perfluorinated compounds in the Region Sauerland also revealed high contamination of fish with PFOS. We observed high PFOS levels in plasma of anglers which was clearly related to the consumption of fish caught from the Möhnelake. Due to uncertainties and inconsistencies in the epidemiological studies, no health-based HBM values for perfluorinated compounds in blood could be set from the available data yet. A further approach to interpret perfluorinated compounds levels in HBM is to derive HBM values from corresponding tolerable intake doses, such like the tolerable daily intake (TDI). This concept has been proposed by the German Human Biomonitoring Commission (2007). The Commission is aware of the uncertainties of such derivation and estimates.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
previous chapter Perfluorinated Compounds in Food
Literature
1.
Angerer J, Ewers U, Wilhelm M (2007) Human biomonitoring: state of the art. Int J Hyg Environ Health 210:201–228CrossRef
2.
Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL (2007) Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ Health Perspect 115(11):1596–602CrossRef
3.
Haug LS, Thomsen C, Becher G (2009) Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 43:2131–2136CrossRef
4.
Haug LS, Thomsen C, Becher G (2009) A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J Chromatogr A 1216:385–393CrossRef
5.
Mosch C, Kiranoglu M, Fromme H, Völkel W (2010) Simultaneous quantification of perflouroalkyl acids in human serum and breast milk using on-line sample preparation by HPLC column switching coupled to ESI-MS/M. J Chromatogr B Anal Technol Biomed Life Sci 878:2652–2658CrossRef
6.
Longnecker MP, Smith CS, Kissling GE, Hoppin JA, Butenhoff JL, Decker E, Ehresman DJ, Ellefson ME, Flaherty J, Gardner MS, Langlois E, Leblanc A, Lindstrom AB, Reagen WK, Strynar MJ, Studabaker WB (2008) An interlaboratory study of perfluorinated alkyl compound levels in human plasma. Environ Res 107:152–9CrossRef
7.
Ehresman DJ, Froehlich JW, Olsen GW, Chang S-C, Butenhoff JL (2007) Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOA), and other fluorochemicals. Environ Res 103:176–184CrossRef
8.
Kärrman A, van Bavel B, Järnberg U, Hardell L, Lindström G (2006) Perfluorinated chemicals in relation to other persistent organic pollutants in human blood. Chemosphere 64:1582–1591CrossRef
9.
Völkel W, Genzel-Boroviczény O, Demmelmair H, Gebauer C, Koletzko B, Twardella D, Raab U, Fromme H (2008) Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. Int J Hyg Environ Health 211:440–446CrossRef
10.
Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, Faber F, Hannibal I, Genzel-Boroviczény O, Koletzko B, Völkel W (2010) Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 44:7123–7129CrossRef
11.
Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O’Neill EM, Mandel JH, Zobel LR (2003) Perfluorooctane sulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111:1892–1901CrossRef
12.
Fromme H, Tittlemier SA, Völkel W, Wilhelm M, Twardella D (2009) Perfluorinated compounds – exposure assessment for the general population in Western countries. Int J Hyg Environ Health 212:239–270CrossRef
13.
Hemat H, Wilhelm M, Völkel W, Mosch C, Fromme H, Wittsiepe J (2010) Low serum levels of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) in children and adults from Afghanistan. Sci Total Environ 408:3493–3495CrossRef
14.
Kannan K, Corsolini S, Falandysz J, Fillmann K, Kumar KS, Loganathan BG, Mohd MA, Olivero J, Van Wouwe N, Yang JH, Aldous KM (2004) Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38:4489–4495CrossRef
15.
Guruge KS, Taniyasu S, Yamashita N, Wijeratna S, Mohotti KM, Seneviratne HR, Kannan K, Yamanaka N, Miyazaki S (2005) Perfluorinated organic compounds in human serum and seminal plasma: a study of urban and rural tea worker populations in Sri Lanka. J Environ Monit 7:371–377CrossRef
16.
Calafat AM, Needham LL, Kuklenyik Z, Reidy JA, Tully JS, Aguilar-Villalobos M, Naeher LP (2006) Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63:490–496CrossRef
17.
Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM (2006) Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 2006(48):759–770
18.
Frisbee SJ, Brooks AP Jr, Maher A, Flensborg P, Arnold S, Fletcher T, Steenland K, Shankar A, Knox SS, Pollard C, Halverson JA, Vieira VM, Jin C, Leyden KM, Ducatman AM (2009) The C8 health project: design, methods, and participants. Environ Health Perspect 117:1873–1882
19.
Wilhelm M, Kraft M, Rauchfuss K, Hölzer J (2008) Assessment and management of the first German case of a contamination with perfluorinated compounds (PFC) in the Region Sauerland, North Rhine-Westphalia. J Toxicol Environ Health A 71:725–733CrossRef
20.
21.
Hölzer J, Midasch O, Rauchfuss K, Kraft M, Reupert R, Angerer J, Kleeschulte P, Marschall N, Wilhelm M (2008) Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water. Environ Health Perspect 116:651–657CrossRef
22.
Skutlarek D, Exner M, Färber H (2006) Perfluorinated surfactants in surface and drinking waters. Environ Sci Pollut Res Int 13:299–307CrossRef
23.
Brede E, Wilhelm M, Göen T, Müller J, Rauchfuss K, Kraft M, Hölzer J (2010) Two-year follow-up biomonitoring pilot study of residents’ and controls’ PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 213:217–223CrossRef
24.
Hölzer J, Göen T, Rauchfuss K, Kraft M, Angerer J, Kleeschulte P, Wilhelm M (2009) One-year follow-up of perfluorinated compounds in plasma of German residents from Arnsberg formerly exposed to PFOA-contaminated drinking water. Int J Hyg Environ Health 212:499–504CrossRef
25.
Wilhelm M, Bergmann S, Dieter HH (2010) Occurrence of perfluorinated compounds (PFCs) in drinking water of North Rhine-Westphalia, Germany and new approach to assess drinking water contamination by shorter-chained C4–C7 PFCs. Int J Hyg Environ Health 213:224–232CrossRef
26.
Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394CrossRef
27.
Chang SC, Das K, Ehresman DJ, Ellefson ME, Gorman GS, Hart JA, Noker PE, Tan YM, Lieder PH, Lau C, Olsen GW, Butenhoff JL (2008) Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water. Toxicol Sci 104:40–53CrossRef
28.
Olsen GW, Burris JM, Ehresmann DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR (2008) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanesulfonate in retired fluorochemical production workers. Environ Health Perspect 115:1298–1305CrossRef
29.
Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K (2010) Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 118:222–228CrossRef
30.
Olsen GW, Huang H-Y, Helzlsouer KJ, Hansen KJ, Butenhoff JL, Mandel JH (2005) Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ Health Perspect 113:539–545CrossRef
31.
Olsen GW, Mair DC, Reagan WK, Ellefson ME, Ehresman DJ, Butenhoff JL, Zobel LR (2007) Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere 68:105–111CrossRef
32.
Olsen GW, Mair DC, Church TR, Ellefson ME, Reagen WK, Boyd TM, Herron RM, Medhdizadehkashi Z, Nobiletti JB, Rios JA, Butenhoff JL, Zobel LR (2008) Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000–2006. Environ Sci Technol 42:4989–4995CrossRef
33.
Harada K, Koizumi A, Saito N, Inoue K, Yoshinaga T, Date C, Fujii S, Hachiya N, Hirosawa I, Koda S, Kusaka Y, Murata K, Omae K, Shimbo S, Takenaka K, Takeshita T, Todoriki H, Wada Y, Watanabe T, Ikeda M (2007) Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Chemosphere 66:293–301CrossRef
34.
Harada K, Saito N, Inoue K, Yoshinaga T, Watanabe T, Sasaki S, Kamiyama S, Koizumi A (2004) The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years. J Occup Health 46:141–147CrossRef
35.
Jin Y, Saito N, Harada KH, Inoue K, Koizumi A (2007) Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulphate in Shenyang China. Tohoku J Exp Med 212:63–70CrossRef
36.
Kärrmann A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A, Lignell S, Lindström G (2007) Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996–2004, in Sweden. Environ Health Perspect 115:226–230CrossRef
37.
Sundström M, Ehresman DJ, Bignert A, Butenhoff JL, Olsen GW, Chang SC, Bergman A (2011) A temporal trend study (1972–2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm Sweden. Environ Int 37:178–183CrossRef
38.
Human Biomonitoring Commission (2009) Umweltbundesamt, Referenzwerte für Perfluoroctansäure (PFOA) und Perfluoroctansulfonsäure (PFOS) im Blutplasma. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 52:878–885CrossRef
39.
Wilhelm M, Angerer J, Fromme H, Hölzer J (2009) Contribution to the evaluation of reference values for PFOA and PFOS in plasma of children and adults from Germany. Int J Hyg Environ Health 212:56–60CrossRef
40.
Falandysz J, Taniyasu S, Gulkowska A, Yamashita N, Schulte-Oehlmann U (2006) Is fish a major source of fluorinated surfactants and repellents in humans living on the Baltic Coast? Environ Sci Technol 40:748–751CrossRef
41.
Haug LS, Thomsen C, Brantsaeter AL, Kvalem HE, Haugen M, Becher G, Alexander J, Meltzer HM, Knutsen HK (2010) Diet and particularly seafood are major sources of perfluorinated compounds in humans. Environ Int 36:772–778CrossRef
42.
Hölzer J, Göen T, Just P, Reupert R, Rauchfuss K, Kraft M, Müller J, Wilhelm M (2011) Perfluorinated Compounds in Fish and Blood of Anglers at Lake M–hne, Sauerland Area, Germany. Environ Sci Technol dx.​doi.​org/​10.​1021/​es104391z.
43.
Lundin JI, Alexander BH, Olsen GW, Church TR (2009) Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 20:921–928CrossRef
44.
Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR (2007) Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49:872–879CrossRef
45.
Leonard RC, Kreckmann KH, Sakr CJ, Symons JM (2008) Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18:15–22CrossRef
46.
Fei C, McLaughlin JK, Tarone RE, Olsen J (2007) Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115:1677–1682CrossRef
47.
Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, Goldman LR (2007) Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115:1670–1676CrossRef
48.
Hamm MP, Cherry NM, Chan E, Martin JW, Burstyn I (2010) Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol 20:589–597CrossRef
49.
Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B, Foster WG (2008) Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108:56–62CrossRef
50.
Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, Ito R, Nakata A, Iwasaki Y, Saito K, Nakazawa H, Kishi R (2009) Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 117:660–667
51.
Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmet EA (2009) The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27:231–238CrossRef
52.
Fei C, McLaughlin JK, Lipworth L, Olsen J (2009) Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 24:1200–1205CrossRef
53.
Human Biomonitoring Commission (2007) Umweltbundesamt, Derivation of human biomonitoring (HBM) values based on tolerable intake doses. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50:251–254, in GermanCrossRef
54.
Hays SM, Becker RA, Leung HW, Aylward LL, Pyatt DW (2007) Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul Toxicol Pharmacol 47:96–109CrossRef
Metadata
Title
Human Biomonitoring of Perfluorinated Compounds
Authors
Michael Wilhelm
Jürgen Hölzer
Copyright Year
2012
Publisher
Springer Berlin Heidelberg
Book
Polyfluorinated Chemicals and Transformation Products

Print ISBN: 978-3-642-21871-2

Electronic ISBN: 978-3-642-21872-9

Copyright Year: 2012

DOI
https://doi.org/10.1007/978-3-642-21872-9_8